NFE2L2 and central nervous system cancer: Research has shown that neuronal precursor cell-expressed developmentally downregulated 4-1 (NEDD4-1) induces resistance to TMZ treatment in gliomas via activating the AKT/NRF2/HO-1 axis [91].